Favorable Outcome of Pregnancy with an Elective Use of Epoprostenol and Sildenafil in Women with Severe Pulmonary Hypertension

Background: Pulmonary hypertension carries significant maternal and fetal risk during pregnancy and the postpartum period. As maternal mortality is high, specific targeted therapy for pulmonary hypertension may be required during pregnancy. Cases: We describe 2 pregnant patients who presented with s...

Full description

Saved in:
Bibliographic Details
Published inCardiology Vol. 115; no. 3; pp. 205 - 208
Main Authors Goland, Sorel, Tsai, Fausen, Habib, Munira, Janmohamed, Munir, Goodwin, T. Murphy, Elkayam, Uri
Format Journal Article
LanguageEnglish
Published Basel, Switzerland S. Karger AG 01.01.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background: Pulmonary hypertension carries significant maternal and fetal risk during pregnancy and the postpartum period. As maternal mortality is high, specific targeted therapy for pulmonary hypertension may be required during pregnancy. Cases: We describe 2 pregnant patients who presented with severe secondary pulmonary arterial hypertension during their last trimester. They were electively treated in the late antepartum and early postpartum periods with sildenafil and intravenous epoprostenol and successfully delivered healthy infants via cesarean section without postpartum complications. Conclusion: Although pulmonary hypertension is associated with a risk of maternal mortality and most women are advised against pregnancy, new therapies may improve the outcome of pregnancy in patients with pulmonary hypertension.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0008-6312
1421-9751
DOI:10.1159/000287638